Webinar Hosted by Xtalks to cover actions pharmaceutical commercial teams can take to stay on track with 2020 goals

COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in-line and launch brands to meet the new reality of customer and business needs during the ongoing pandemic.

This webinar will cover the actions that pharmaceutical commercial teams can take now to stay on track with 2020 goals and to plan for 2021. Pharmaceutical and biotech commercialization teams will hear about trends in the marketplace during the last few months of marketing, medical affairs, market access strategy and customer communication during COVID-19. We will discuss the choices teams have made and the rationale for different approaches. Whether you are seeking to re-start pharmaceutical commercialization or planning for a new launch, the short and long-term planning guidance discussed will be of value.